Eunkyung Kim

Eunkyung Kim currently serves as the Head of Medical and Clinical Development at ABL Bio Inc. since May 2022. Previously, Eunkyung held multiple senior roles at Bristol Myers Squibb from September 2016 to December 2021, including Oncology TA Head for Clinical Development in Japan and Lead of Development Strategy and Innovation for Japan, Korea, and Taiwan. Eunkyung also worked as Medical Director for Novartis Oncology in Korea from March 2008 to August 2016 and as Senior Medical Advisor. Eunkyung Kim earned a Doctor of Philosophy (Ph.D.) in molecular oncology, a Master's degree in molecular oncology, and a Doctor of Medicine (M.D.) from Seoul National University, along with additional studies at the University of Basel.